MONTREAL, CANADA--(Marketwire - November 06, 2007) - Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, today announced that it has submitted a patent application for its novel oral ingestible film composition delivery system, Thinsol™. Thinsol™ is a water-based, enzymatically-digested carboxymethylcellulose (CMC-enz) film that is suitable for the rapid delivery of pharmaceutical and nutraceutical active ingredients.
